Viewing Option
MNG Tracker anticipated that numbers of clinical trials and regulatory approvals for cell and gene therapies are expected to rise over the years to come. The US FDA anticipates that by 2025 it will approve 10 to 20 cell and gene therapy products per year. It is expected that the global cell and gene....
The global CAR-T Cell therapy market is anticipated to grow over 20 percent CAGR during the forecasting period and likely to touch nearly US$ 8 Billion landmarks in 2028. The year 2017 was the milestone year for the CAR-T therapy as US FDA has approved two CAR-T cell therapies Kymriah in August 2017....